Calithera Biosciences (NASDAQ: CALA) to announce new clinical data from the solid tumor expansion cohorts of its lead anti-cancer therapeutic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE